6062.T
Charm Care Corporation [6062.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6062.T Stock Summary
Top 10 Correlated ETFs
6062.T
Top 10 Correlated Stocks
6062.T
In the News
6062.T Financial details
Company Rating
Strong Buy
Market Cap
51.63B
Income
3.59B
Revenue
41.62B
Book val./share
476.78
Cash/share
45.93
Dividend
22
Dividend %
1.79%
Employees
2K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
12.16
Forward P/E
-
PEG
5.68
P/S
0.99
P/B
2.7
P/C
32.29
P/FCF
-
Quick Ratio
0.41
Current Ratio
1.04
Debt / Equity
0.93
LT Debt / Equity
0.41
-
-
EPS (TTM)
109.86
EPS next Y
-
EPS next Q
-
EPS this Y
8.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.27%
Revenue last 5Y
18%
Revenue Q/Q
-14.33%
EPS Q/Q
46.81%
-
-
-
-
SMA20
5.48%
SMA50
29.57%
SMA100
32.43%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
24%
ROC
0.19%
Gross Margin
17%
Oper. Margin
11%
Profit Margin
8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1039.0-1677.0
52W High
-11.57%
52W Low
+42.73%
RSI
46
Rel Volume
0.94
Avg Volume
148.17K
Volume
139.8K
Perf Week
-7.14%
Perf Month
7.62%
Perf Quarter
34.57%
Perf Half Y
34.7%
-
-
-
-
Beta
0.807
-
-
Volatility
36.32%, 63.29%
Prev Close
-1.98%
Price
1483
Change
-4.08%
6062.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
| Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 589.97 | 640.42 | 704.85 | 891.39 | 1.16K | |
| Net income per share | 35.96 | 39.4 | 47.09 | 90.48 | 98.26 | |
| Operating cash flow per share | 74.3 | 39.69 | 78.47 | 120.99 | 15.2 | |
| Free cash flow per share | 51.24 | 24.07 | 3.8 | 40.98 | -49.56 | |
| Cash per share | -166.4 | -67.01 | 36.03 | 48.86 | 25.62 | |
| Book value per share | 163.34 | 320.62 | 341.2 | 382.01 | 463.89 | |
| Tangible book value per share | 159.36 | 317.32 | 324.38 | 287.46 | 375.83 | |
| Share holders equity per share | 163.34 | 320.62 | 341.2 | 382.01 | 463.89 | |
| Interest debt per share | 249.31 | 210.48 | 256.34 | 335.69 | 405.1 | |
| Market cap | 24B | 25.83B | 39.65B | 31.21B | 42.22B | |
| Enterprise value | 28.7B | 26.61B | 42.02B | 35.15B | 48.56B | |
| P/E ratio | 23.78 | 21.4 | 25.82 | 10.58 | 13.17 | |
| Price to sales ratio | 1.45 | 1.32 | 1.73 | 1.07 | 1.11 | |
| POCF ratio | 11.51 | 21.24 | 15.5 | 7.91 | 85.12 | |
| PFCF ratio | 16.69 | 35.02 | 319.76 | 23.35 | -26.11 | |
| P/B Ratio | 5.23 | 2.63 | 3.56 | 2.51 | 2.79 | |
| PTB ratio | 5.23 | 2.63 | 3.56 | 2.51 | 2.79 | |
| EV to sales | 1.73 | 1.36 | 1.83 | 1.21 | 1.28 | |
| Enterprise value over EBITDA | 15.53 | 11.43 | 14.61 | 10.52 | 8.76 | |
| EV to operating cash flow | 13.76 | 21.88 | 16.42 | 8.91 | 97.91 | |
| EV to free cash flow | 19.95 | 36.09 | 338.88 | 26.3 | -30.03 | |
| Earnings yield | 0.04 | 0.05 | 0.04 | 0.09 | 0.08 | |
| Free cash flow yield | 0.06 | 0.03 | 0 | 0.04 | -0.04 | |
| Debt to equity | 1.51 | 0.65 | 0.75 | 0.87 | 0.87 | |
| Debt to assets | 0.37 | 0.27 | 0.29 | 0.29 | 0.3 | |
| Net debt to EBITDA | 2.54 | 0.34 | 0.82 | 1.18 | 1.14 | |
| Current ratio | 0.87 | 1.66 | 1.25 | 1.05 | 1.07 | |
| Interest coverage | 26.89 | 38.2 | 42.64 | 34.16 | 72.36 | |
| Income quality | 1.27 | 0.66 | 1.12 | 0.87 | 0.1 | |
| Dividend Yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.07 | 0.12 | 0.14 | 0.13 | 0.17 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0.02 | 0.08 | 0.07 | |
| Capex to operating cash flow | -0.31 | -0.39 | -0.95 | -0.66 | -4.26 | |
| Capex to revenue | -0.04 | -0.02 | -0.11 | -0.09 | -0.06 | |
| Capex to depreciation | -1.57 | -1.08 | -4.78 | -3.37 | -2.47 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 363.54 | 533.11 | 601.26 | 881.88 | 1.01K | |
| ROIC | 0.07 | 0.08 | 0.07 | 0.06 | 0.1 | |
| Return on tangible assets | 0.05 | 0.05 | 0.05 | 0.09 | 0.08 | |
| Graham Net | -618.67 | -461.87 | -431.15 | -514.62 | -573.82 | |
| Working capital | -658.12M | 3.45B | 1.96B | 798.34M | 1.39B | |
| Tangible asset value | 4.47B | 9.72B | 10.58B | 9.38B | 12.26B | |
| Net current asset value | -9.89B | -5.51B | -7.68B | -7.82B | -6.72B | |
| Invested capital | 1.51 | 0.65 | 0.75 | 0.87 | 0.87 | |
| Average receivables | 1.92B | 2.14B | 2.25B | 4.64B | 7.33B | |
| Average payables | 155.86M | 184.11M | 211.24M | 243.11M | 282.12M | |
| Average inventory | 4.64M | 375.62M | 929.57M | 1.79B | 4.14B | |
| Days sales outstanding | 44.78 | 41.85 | 35.61 | 88.4 | 73.37 | |
| Days payables outstanding | 4.48 | 4.56 | 4.26 | 3.95 | 3.53 | |
| Days of inventory on hand | 0.09 | 17.02 | 21.31 | 37.03 | 68.17 | |
| Receivables turnover | 8.15 | 8.72 | 10.25 | 4.13 | 4.97 | |
| Payables turnover | 81.39 | 80 | 85.75 | 92.42 | 103.5 | |
| Inventory turnover | 4.06K | 21.45 | 17.13 | 9.86 | 5.35 | |
| ROE | 0.22 | 0.12 | 0.14 | 0.24 | 0.21 | |
| Capex per share | -23.06 | -15.62 | -74.67 | -80.01 | -64.76 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 229.91 | 233.99 | 472 | 306.81 | 262.6 | |
| Net income per share | 12.11 | 11.71 | 63.35 | 14.1 | 20.7 | |
| Operating cash flow per share | 13 | 13.06 | 13.61 | 13.12 | 13.29 | |
| Free cash flow per share | 13 | 13.06 | 13.61 | 13.12 | 13.29 | |
| Cash per share | -22.63 | -100.09 | 25.62 | 18.94 | 45.93 | |
| Book value per share | 388.84 | 400.41 | 463.85 | 456.03 | 476.78 | |
| Tangible book value per share | 297.54 | 310.43 | 375.8 | 368.83 | 383.73 | |
| Share holders equity per share | 388.84 | 400.41 | 463.85 | 456.03 | 476.78 | |
| Interest debt per share | 430.9 | 444.32 | 403.81 | 410.94 | 442.4 | |
| Market cap | 41.26B | 36.09B | 42.22B | 38.18B | 41.38B | |
| Enterprise value | 50.98B | 48.72B | 48.57B | 45.65B | 48.95B | |
| P/E ratio | 26.11 | 23.62 | 5.11 | 20.75 | 15.3 | |
| Price to sales ratio | 5.5 | 4.73 | 2.74 | 3.81 | 4.82 | |
| POCF ratio | 97.31 | 84.71 | 95.1 | 89.2 | 95.34 | |
| PFCF ratio | 97.31 | 84.71 | 95.1 | 89.2 | 95.34 | |
| P/B Ratio | 3.25 | 2.76 | 2.79 | 2.57 | 2.66 | |
| PTB ratio | 3.25 | 2.76 | 2.79 | 2.57 | 2.66 | |
| EV to sales | 6.8 | 6.38 | 3.15 | 4.56 | 5.71 | |
| Enterprise value over EBITDA | 80.92 | 78.97 | 16.9 | 62.87 | 46.53 | |
| EV to operating cash flow | 120.23 | 114.37 | 109.39 | 106.65 | 112.79 | |
| EV to free cash flow | 120.23 | 114.37 | 109.39 | 106.65 | 112.79 | |
| Earnings yield | 0.01 | 0.01 | 0.05 | 0.01 | 0.02 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 1.11 | 1.11 | 0.87 | 0.9 | 0.93 | |
| Debt to assets | 0.35 | 0.35 | 0.3 | 0.31 | 0.32 | |
| Net debt to EBITDA | 15.42 | 20.48 | 2.21 | 10.29 | 7.2 | |
| Current ratio | 0.99 | 0.98 | 1.07 | 1.04 | 1.04 | |
| Interest coverage | 40.55 | 22.68 | 166.41 | 63 | 73.08 | |
| Income quality | 1.07 | 1.12 | 0.21 | 0.93 | 0.64 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 325.5 | 324.76 | 813.1 | 380.33 | 471.22 | |
| ROIC | 0.01 | 0.01 | 0.07 | 0.02 | 0.02 | |
| Return on tangible assets | 0.01 | 0.01 | 0.05 | 0.01 | 0.02 | |
| Graham Net | -594.4 | -645.09 | -573.76 | -571.48 | -580.09 | |
| Working capital | -263M | -359M | 1.39B | 909M | 790M | |
| Tangible asset value | 9.71B | 10.13B | 12.26B | 12.04B | 12.53B | |
| Net current asset value | -8.39B | -8.48B | -6.72B | -6.94B | -7.01B | |
| Invested capital | 1.11 | 1.11 | 0.87 | 0.9 | 0.93 | |
| Average receivables | 7.25B | 7.36B | 7.49B | 7.7B | 7.96B | |
| Average payables | 283.5M | 293.5M | 298M | 304.5M | 318M | |
| Average inventory | 6.54B | 7.76B | 7.32B | 6.1B | 6.87B | |
| Days sales outstanding | 88.36 | 86.73 | 44.51 | 69.93 | 85.46 | |
| Days payables outstanding | 4.09 | 4.08 | 2.26 | 3.24 | 4.21 | |
| Days of inventory on hand | 93.95 | 121.85 | 43.63 | 67.1 | 94.56 | |
| Receivables turnover | 1.02 | 1.04 | 2.02 | 1.29 | 1.05 | |
| Payables turnover | 21.98 | 22.08 | 39.87 | 27.78 | 21.36 | |
| Inventory turnover | 0.96 | 0.74 | 2.06 | 1.34 | 0.95 | |
| ROE | 0.03 | 0.03 | 0.14 | 0.03 | 0.04 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
6062.T Frequently Asked Questions
What is Charm Care Corporation stock symbol ?
Charm Care Corporation is a JP stock and trading under the symbol 6062.T
What is Charm Care Corporation stock quote today ?
Charm Care Corporation stock price is $1483 today.
Is Charm Care Corporation stock public?
Yes, Charm Care Corporation is a publicly traded company.
Company Profile
- Volume Average 148.17K
- Market Capitalization 51.63B
- Employee 2K
- CEO Mr. Takahiko Shimomura
- Headquarters Osaka,JP
- IPO Date 2012-04-27
-
Website
https://www.charmcc.jp 
Charm Care Corporation engages in nursing care business. It operates pay nursing homes with approximately 4,191 rooms in the Tokyo metropolitan and Kinki areas. The company was formerly known as Fuji Clinic Laboratory and changed its name to Charm Care Corporation in December 2007. Charm Care Corporation was incorporated in 1984 and is headquartered in Osaka, Japan.
